Evidence map›Paper›PMID 38746242›Full record

ArticlebioRxiv : the preprint server for biology2024

Downregulation of PIK3IP1/TrIP on T cells is controlled by TCR signal strength, PKC and metalloprotease-mediated cleavage.

Benjamin M Murter, Sean C Robinson, Hridesh Banerjee, Louis Lau, Uzodinma U Uche, Andrea L Szymczak-Workman, Lawrence P Kane

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Benjamin M MurterDept. of Immunology, University of Pittsburgh, Pittsburgh PA, USA.
Sean C RobinsonDept. of Immunology, University of Pittsburgh, Pittsburgh PA, USA.
Hridesh BanerjeeDept. of Immunology, University of Pittsburgh, Pittsburgh PA, USA.
Louis LauDept. of Immunology, University of Pittsburgh, Pittsburgh PA, USA.
Uzodinma U UcheDept. of Immunology, University of Pittsburgh, Pittsburgh PA, USA.
Andrea L Szymczak-WorkmanDept. of Immunology, University of Pittsburgh, Pittsburgh PA, USA.
Lawrence P KaneDept. of Immunology, University of Pittsburgh, Pittsburgh PA, USA.ORCID 0000-0001-5198-516X

Funding

Training in Cellular & Molecular Mechanisms of Tumor RejectionT32CA082084 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Robert J Binder, Dario AA Vignali · 1999 to 2026
$9.2M
Regulation of PI3K by PIK3IP1/TrIPR01GM136148 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KANE, LAWRENCE P. · 2020 to 2023
$1.3M
Elucidating The Roles of PIK3IP1/TrIP Regulation on Distinct T Cell Subsets in the Context of CancerF31CA261039 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MURTER, BENJAMIN · 2022 to 2024
$117k
NCI NIH HHS F31 CA261039NCI NIH HHS T32 CA082084NIGMS NIH HHS R01 GM136148
6 · The paper itself

Abstract

The protein known as PI3K-interacting protein (PIK3IP1), or transmembrane inhibitor of PI3K (TrIP), is highly expressed by T cells and can modulate PI3K activity in these cells. Several studies have also revealed that TrIP is rapidly downregulated following T cell activation. However, it is unclear as to how this downregulation is controlled. Using a novel monoclonal antibody that robustly stains cell-surface TrIP, we demonstrate that TrIP is lost from the surface of activated T cells in a manner dependent on the strength of signaling through the T cell receptor (TCR) and specific downstream signaling pathways, in particular classical PKC isoforms. TrIP expression returns by 24 hours after stimulation, suggesting that it may play a role in resetting TCR signaling at later time points. We also provide evidence that ADAM family proteases are required for both constitutive and stimulation-induced downregulation of TrIP in T cells. Finally, by expressing truncated forms of TrIP in cells, we identify the region in the extracellular stalk domain of TrIP that is targeted for proteolytic cleavage.

Indexed as

ADAMcell signalingcellular immune responsematrix metalloproteinase (MMP)phosphatidylinositide 3-kinase (PI 3-kinase)PIK3IP1T-cellT-cell receptor (TCR)TrIP

Identifiers

PMID38746242
PMCPMC11092459

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.